Major IP Groups Urge Full Fed. Circ. To Eye AIA On-Sale Bar
By Ryan Davis (July 19, 2017, 8:44 PM EDT) -- Many major intellectual property groups urged the full Federal Circuit on Wednesday to review a decision that sales in which an invention isn't publicly disclosed invalidate patents under the America Invents Act's on-sale bar rule, with one saying the ruling threatens to "destabilize the entire U.S. patent system."
The Intellectual Property Owners Association, American Intellectual Property Law Association, Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization all filed amicus briefs supporting Helsinn Healthcare SA's request for en banc review, arguing that the panel decision in the case flies in the face of congressional intent in the AIA to limit...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!